Boston Scientific Q1 2024 10-Q Filed
Ticker: BSX · Form: 10-Q · Filed: 2024-05-01T00:00:00.000Z
Sentiment: neutral
Topics: 10-Q, financials, medical-devices
TL;DR
**BSX Q1 2024 10-Q is in! Financials and operations updated. Check it out.**
AI Summary
Boston Scientific Corp. filed its 10-Q for the period ending March 31, 2024. The filing details financial performance and operational updates for the first quarter of 2024. Key financial figures and stock information are presented, reflecting the company's ongoing business activities and market position in the surgical and medical instruments sector.
Why It Matters
This filing provides investors and analysts with the latest financial health and operational details of Boston Scientific, a major player in the medical device industry.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing (10-Q) and does not inherently present new risks.
Key Numbers
- 300 BOSTON SCIENTIFIC WAY — Business Address (Company headquarters location)
- 508-683-4000 — Business Phone (Company contact number)
Key Players & Entities
- BOSTON SCIENTIFIC CORP (company) — Filer
- MARLBOROUGH (location) — Business Address City
- DE (location) — State of Incorporation
- 20240331 (date) — Period of Report
- 20240501 (date) — Filed as of Date
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240331, meaning it covers the first quarter of 2024 ending March 31, 2024.
What is Boston Scientific Corp.'s Standard Industrial Classification code?
Boston Scientific Corp.'s SIC code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.
When was this 10-Q filing submitted?
The filing was submitted on 20240501.
What is the company's fiscal year end?
The company's fiscal year ends on 1231.
Where is Boston Scientific Corp. incorporated?
Boston Scientific Corp. is incorporated in DE (Delaware).
From the Filing
0000885725-24-000046.txt : 20240501 0000885725-24-000046.hdr.sgml : 20240501 20240501160548 ACCESSION NUMBER: 0000885725-24-000046 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 78 CONFORMED PERIOD OF REPORT: 20240331 FILED AS OF DATE: 20240501 DATE AS OF CHANGE: 20240501 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 24902938 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 10-Q 1 bsx-20240331.htm 10-Q bsx-20240331 0000885725 12/31 2024 Q1 false 315 314 341 359 254 0000885725 2024-01-01 2024-03-31 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000885725 bsx:SeniorNotedue2027Member 2024-01-01 2024-03-31 iso4217:USD xbrli:shares 0000885725 2024-04-29 xbrli:shares iso4217:USD 0000885725 2023-01-01 2023-03-31 0000885725 2024-03-31 0000885725 2023-12-31 0000885725 us-gaap:CommonStockMember 2024-03-31 0000885725 us-gaap:PreferredStockMember 2023-12-31 0000885725 us-gaap:PreferredStockMember 2022-12-31 0000885725 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0000885725 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0000885725 us-gaap:PreferredStockMember 2024-03-31 0000885725 us-gaap:PreferredStockMember 2023-03-31 0000885725 us-gaap:CommonStockMember 2023-12-31 0000885725 us-gaap:CommonStockMember 2022-12-31 0000885725 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0000885725 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0000885725 us-gaap:CommonStockMember 2023-03-31 0000885725 us-gaap:TreasuryStockCommonMember 2023-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2022-12-31 0000885725 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0000885725 us-gaap:TreasuryStockCommonMember 2023-01-01 2023-03-31 0000885725 us-gaap:TreasuryStockCommonMember 2024-03-31 0000885725 us-gaap:TreasuryStockCommonMember 2023-03-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0000885725 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0000885725 us-gaap:RetainedEarningsMember 2023-12-31 0000885725 us-gaap:RetainedEarningsMember 2022-12-31 0000885725 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0000885725 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0000885725 us-gaap:RetainedEarningsMember 2024-03-31 0000885725 us-gaap:RetainedEarningsMember 2023-03-31 0000885725 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-12-31 0000885725 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-12-31 0000885725 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0000885725 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-01-01 2023-03-31 0000885725 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0000885725 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2023-03-31 0000885725 2023-03-31 0000885725 us-gaap:NoncontrollingInterestMember 2023-12-31 0000885725 us-gaap:NoncontrollingInterestMember 2022-12-31 0000885725 us-gaap:NoncontrollingInterestMember 2024-01-01 2024-03-31 0000885725 us-gaap:NoncontrollingInterestMember 2023-01-01 2023-03-31 0000885725 us-gaap:NoncontrollingInterestMember 2024-03-31 0000885725 us-gaap:NoncontrollingInterestMember 2023-03-31 0000885725 2022-12-31 0000885725 bsx:AxonicsMember 2024-01-08 xbrli:pure 0000885725 bsx:AxonicsMember 2024-01-08 2024-01-